Trial · NCT03340675
Outcomes15
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Incidence of Treatment-Emergent Adverse Events | Baseline through 12 months | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Pharmacokinetics Area Under the Curve | Pre-dose and at 0.5, 1.0, 4.0, 8.0 and 24.0 h post-dose on Day 0 and pre-dose and 0.5 h post-dose on Day 7 | Fewer participants are represented here due to missing assessments for this measure. | h*ng/mL | MEAN |
| SECONDARY | Pharmacokinetics Maximum Serum Concentration (Cmax) | Pre-dose and at 0.5, 1.0, 4.0, 8.0 and 24.0 h post dose on Day 0 and pre-dose and 0.5 h post-dose on Day 7 | Fewer participants are represented here due to missing assessments for this measure. | ng/mL | MEAN |
| SECONDARY | Pharmacokinetics Time to Reach Cmax (Tmax) Concentration | Pre-dose and at 0.5, 1.0, 4.0, 8.0 and 24.0 h post dose on Day 0 and pre-dose and 0.5 h post-dose on Day 7 | Fewer participants are represented here due to missing assessments for this measure. | h | MEAN |
| SECONDARY | Pharmacokinetics Plasma Terminal Half-life Concentration | Pre-dose and at 0.5, 1.0, 4.0, 8.0 and 24.0 h post dose on Day 0 and pre-dose and 0.5 h post-dose on Day 7 | Fewer participants are represented here due to missing assessments for this measure. | h | MEAN |
| SECONDARY | Change From Baseline in Left Ventricular Ejection Fraction | Baseline visit and Month 12 visit | Differences in number of participants analyzed is due to missing evaluations at one or more timepoint | Percentage of LVEF | MEAN |
| SECONDARY | Change From Baseline in FEV1 | Baseline through month 12 | Differences in number of participants analyzed is due to missing evaluations at one or more timepoint | Liters | MEAN |
| SECONDARY | Change From Baseline in Percent Predicted FEV1 | Baseline through month 12 | Differences in number of participants analyzed is due to missing evaluations at one or more timepoint | Percent | MEAN |
| SECONDARY | Change From Baseline in FVC | Baseline through month 12 | Differences in number of participants analyzed is due to missing evaluations at one or more timepoint | Liters | MEAN |
| SECONDARY | Change From Baseline in Percent Predicted FVC | Baseline through month 12 | Differences in number of participants analyzed is due to missing evaluations at one or more timepoint | Percent | MEAN |
| SECONDARY | Change From Baseline in Maximal Expiratory Pressure | Baseline through month 12 | Differences in number of participants analyzed is due to missing evaluations at one or more timepoint | cm of water | MEAN |
| SECONDARY | Change From Baseline in Maximal Inspiratory Pressure | Baseline through month 12 | Differences in number of participants analyzed is due to missing evaluations at one or more timepoint | cm of water | MEAN |
| SECONDARY | Change From Baseline in Peak Expiratory Flow Rate | Baseline through month 12 | Differences in number of participants analyzed is due to missing evaluations at one or more timepoint | Liters/second | MEAN |
| SECONDARY | Change From Baseline in Percent Predicted Peak Expiratory Flow Rate | Baseline through month 12 | Differences in number of participants analyzed is due to missing evaluations at one or more timepoint | Percent | MEAN |
| SECONDARY | Change From Baseline in Quality-of-life | Baseline through 12 months | Differences in number of participants analyzed is due to missing evaluations at one or more timepoint | Scores on a scale | MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03340675/outcomes